ArticleJournal of thrombosis and haemostasis : JTH2022
Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa.
Stefan Heitmeier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it